Clinical Trials
Ajovy superior to placebo at 12 weeks for episodic migraine in young people
Ajovy offers “significant efficacy” compared with placebo to address episodic migraine in children and adolescents, according to topline results from the phase 3 SPACE study.
Diagnosis of Lupus
Racial representation still lacking in vitiligo clinical trials
Certain racial groups continue to be underrepresented in vitiligo clinical trials, according to a study.
VIDEO: Deep response key benefit of combination therapy in multiple myeloma
FDA accepts supplemental new drug application of Rexulti for PTSD
The FDA has accepted a supplemental new drug application from Otsuka and Lundbeck for Rexulti in combination with sertraline to treat adults with PTSD.
Racial, ethnic minorities have similar outcomes in phase 1 trials for advanced cancers
Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.
Interim phase 1/2a study results positive for investigational Parkinson’s cell therapy
A South Korean biomedical company has announced positive 1-year assessment data from a phase 1/2a clinical trial of a human embryonic stem cell-derived midbrain dopaminergic progenitor for Parkinson’s disease.
Mission Therapeutics receives $5.2M to advance novel small-molecule Parkinson’s therapy
Mission Therapeutics has been awarded $5.2 million from The Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s UK to advance a selective, small molecule, brain penetrant USP30 inhibitor for Parkinson’s disease.
VIDEO: Phase 3 dry AMD trial focuses on protecting photoreceptors
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Reenie McCarthy of Stealth BioTherapeutics discusses a phase 3 clinical trial of elamipretide in dry age-related macular degeneration.